Just been digging through the chemicals sector and honestly, it's a mixed bag right now. The whole diversified chemicals space is getting hammered by some pretty serious headwinds - soft demand across construction, consumer durables, and electronics. Europe's still struggling from the Russia-Ukraine situation, and China's real estate market isn't helping demand either. Add in those tariff pressures and you've got a recipe for margin compression.

That said, some companies are actually doing smart things here. They're cutting costs aggressively, raising prices where they can, and focusing on efficiency. The industry's basically betting on self-help measures to survive this rough patch. Looking at the valuations, we're trading around 21.69X EV/EBITDA - actually below the S&P 500, which could signal opportunity for patient investors.

So here are three I've been watching closely:

Albemarle is the obvious play if you believe in the lithium story. They're positioned beautifully in battery-grade lithium and EV demand. Management's executing well on capacity expansion and they've got some serious cost discipline happening. The earnings projections for 2026 are wild - they've beaten estimates consistently and the growth trajectory is hard to ignore.

DuPont's another one catching my attention. They've shifted focus to higher-margin segments like electronics, transportation, and healthcare. The Spectrum Plastics acquisition was smart - it gives them exposure to medical devices, which is more resilient than basic commodities. They're also disciplined about R&D spending and cash returns. The productivity initiatives are actually showing up in the numbers.

Air Products rounds out my watchlist. They're executing on their gasification strategy and these projects should drive real earnings and cash flow accretion. The productivity improvements are tangible and should help them maintain margins even if demand stays soft. They've got solid momentum and management seems to be executing the playbook.

What's interesting is how these three are all taking different angles on the same problem - whether it's lithium upside, healthcare exposure, or operational excellence. The broader sector might be struggling, but there's definitely differentiation here if you dig into the details.